Workman Gail, Bradshaw Amy D
Matrix Biology Program, Benaroya Research Institute, Seattle, WA, United States.
Gazes Cardiac Research Institute, Medical University of South Carolina, Charleston, SC, United States; Ralph H. Johnson Department of Veteran's Affairs Medical Center, Charleston, SC, United States.
Methods Cell Biol. 2018;143:335-345. doi: 10.1016/bs.mcb.2017.08.020. Epub 2017 Dec 1.
The matricellular protein SPARC (secreted protein acidic and rich in cysteine, also known as osteonectin or as BM-40) is a collagen-binding protein with a capacity to induce cell rounding and influence proliferation in cultured cells. In mice that do not express SPARC, fibrillar collagen is reduced in some adult tissues; notably, a reduction in fibrosis is reported in response to fibrotic stimuli in lungs, heart, skin, liver, and in the eye. Recently, mutations in the gene encoding SPARC were found in patients afflicted with osteogenesis imperfecta. Thus, SPARC appears to be a critical mediator of collagen deposition and assembly in tissues. A useful tool for assessing the function of SPARC in ECM assembly is a source of purified recombinant SPARC. Outlined in this chapter is a brief discussion of different strategies for generating recombinant SPARC and an experimental strategy for producing and purifying human recombinant SPARC driven by baculoviral expression in insect cells.
基质细胞蛋白SPARC(分泌性酸性富含半胱氨酸蛋白,也称为骨连接蛋白或BM-40)是一种胶原结合蛋白,能够诱导培养细胞变圆并影响其增殖。在不表达SPARC的小鼠中,某些成年组织中的纤维状胶原减少;值得注意的是,据报道,在肺、心脏、皮肤、肝脏和眼睛中,对纤维化刺激的反应中纤维化减少。最近,在患有成骨不全症的患者中发现了编码SPARC的基因突变。因此,SPARC似乎是组织中胶原沉积和组装的关键介质。评估SPARC在细胞外基质组装中功能的一个有用工具是纯化的重组SPARC来源。本章概述了生成重组SPARC的不同策略的简要讨论,以及在昆虫细胞中由杆状病毒表达驱动生产和纯化人重组SPARC的实验策略。